• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy
  • Reports
    • Diabetes Technology Innovations Special Report
    • Continuous Glucose Monitoring (CGM) Market Report

Research & Development

Nanoparticles permeate lungs to deliver pulmonary drugs

April 11, 2017 By Sarah Faulkner

Lungs

Researchers from Johns Hopkins University have developed nanoparticles that can shuttle chemicals through the thick mucus membranes of pulmonary airways to deliver drugs. The team’s work was published in the journal Science Advances.  Traditional therapies for cystic fibrosis, COPD and asthma include inhaled corticosteroids that adhere to the walls of air passages. Thick mucus tends to build […]

Filed Under: Featured, Nanoparticles, Preclinical Trials, Research & Development, Respiratory Tagged With: Johns Hopkins

CRISPR uncovers drug compounds in bacterial genome

April 11, 2017 By Sarah Faulkner

Pills

Researchers at the University of Illinois and the Agency for Science, Technology & Research in Singapore are using the gene-editing tool CRISPR-Cas9 to uncover potentially useful drug compounds. The team has used CRISPR-Cas9 to turn on “silent” gene clusters in Streptomyces and express genes that naturally produce drug compounds to be used as antibiotics or […]

Filed Under: Discovery, Featured, Pharmaceuticals, Research & Development Tagged With: University of Illinois

Canadian government, JDRF ink $30m partnership to support diabetes research

April 10, 2017 By Sarah Faulkner

JDRF

Canada’s Minister of Health, Jane Philpott, said today that the Canadian Institutes of Health Research inked a $30 million partnership with the Juvenile Diabetes Research Foundation to support clinical research for Type I diabetes. Both groups have agreed to invest $15 million to the deal. “The government of Canada recognizes the impact that Type I diabetes […]

Filed Under: Clinical Trials, Diabetes, Featured, Funding Roundup, Research & Development, Wall Street Beat Tagged With: Canadian Institutes of Health Research, Juvenile Diabetes Research Foundation (JDRF)

Medtech stories we missed this week: April 7, 2017

April 7, 2017 By Danielle Kirsh

New studies for umbilical cord allografts and tumor targeting were published this week while another company received European CE Marking. Here are some medtech stories we missed this week but thought were still worth mentioning. 1. AMNIOX touts new umbilical cord study AMNIOX Medical announced that it has published the results of 3 studies that demonstrate […]

Filed Under: Clinical Trials, Research & Development Tagged With: Aesculap Implant Systems, AMNIOX, AngioDynamics, Cianna Medical, InVivo Therapeutics, medtech, Nu-Med, Occlutech

Homing system targets drugs to specific neurons

April 7, 2017 By Sarah Faulkner

Homing system targets drugs to specific neurons

Researchers from Duke University and the Howard Hughes Medical Institute have developed a technique to target and deliver drugs to specific types of neurons in the brain. The team argues that this will enable scientists to more accurately study neurological disease while offering a more targeted treatment method. The current method of treatment for neurological […]

Filed Under: Featured, Neurological, Research & Development Tagged With: Duke University

How artificial life spawned a billion-dollar industry

April 6, 2017 By Sarah Faulkner

How artifical life spawned a billion-dollar industry

(Reuters) – Scientists are getting closer to building life from scratch and technology pioneers are taking notice, with record sums moving into a field that could deliver novel drugs, materials, chemicals and even perfumes. Despite ethical and safety concerns, investors are attracted by synthetic biology’s wide market potential and the plummeting cost of DNA synthesis, […]

Filed Under: Business/Financial News, Discovery, Featured, Research & Development, Technology, Wall Street Beat

Liposomal drug delivery system could improve solid tumor treatment

April 5, 2017 By Sarah Faulkner

The oxygen-poor regions of solid tumors usually help make them resistant to chemotherapy and other forms of treatment. But researchers at Oregon State University have devised away to take advantage of those hypoxic areas and improve solid tumor treatment with a targeted, liposomal drug delivery system. The team used the cancer drug, vinblastine, which is […]

Filed Under: Featured, Nanoparticles, Oncology, Pharmaceuticals, Research & Development Tagged With: Oregon State University

Study: Nanoparticles could improve efficacy of cancer immunotherapy

April 4, 2017 By Sarah Faulkner

Researchers from the University of North Carolina have discovered that they can potentially improve cancer immunotherapy drugs by binding 2 compounds to a single nanoparticle. The team’s work was presented this week at the annual meeting of the American Association for Cancer Research. “Our data shows that 2 compounds on a single nanoparticle will make […]

Filed Under: Featured, Immunotherapy, Oncology, Research & Development, Wall Street Beat Tagged With: University of North Carolina

Researchers mimic bee venom strategy to help drugs get past blood-brain barrier

April 3, 2017 By Sarah Faulkner

Researchers mimic bee venom strategy to help drugs get past blood-brain barrier

Researchers from the Institute for Research in Biomedicine in Barcelona, Spain said yesterday that they have shown in preclinical tests that a bee-venom peptide, apamin, can be used to ferry medications across the blood-brain barrier. Although the blood-brain barrier prevents most things from getting in and flooding the brain, certain peptides in animal venoms can travel […]

Filed Under: Featured, Neurological, Pharmaceuticals, Research & Development Tagged With: Institute for Research in Biomedicine

Medtech stories we missed this week: March 31, 2017

March 31, 2017 By Danielle Kirsh

This week we saw a few FDA 510(k) clearances and one of the 1st uses of a next-generation surgical robot in Asia. Here are medtech stories we missed this week but thought were still worth mentioning: 1. Corindus touts first Asian use of next-generation robot Corindus Vascular Robotics announced in a March 31 press release that robot-assisted […]

Filed Under: Business/Financial News, Clinical Trials, Food & Drug Administration (FDA), Personnel, Regulatory/Compliance, Research & Development Tagged With: Aminox, Bodycad, corindus, Engologix, medtech, NeoSurgical, NeoTract, Providence Medical, TissueTech

  • « Go to Previous Page
  • Page 1
  • Interim pages omitted …
  • Page 29
  • Page 30
  • Page 31
  • Page 32
  • Page 33
  • Interim pages omitted …
  • Page 48
  • Go to Next Page »

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.
MDO

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
About
Contact us
Listen to our Weekly Podcasts
Advertise

Copyright © 2026 · Arrowfly LLC. All Rights Reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy | Terms & Conditions | RSS